Introduction {#s1}
============

Hepatitis-C virus (HCV) causes the infectious disease Hepatitis-C which primarily affects the liver. It is important to identify the potential target human proteins that lead to different diseases caused by hepatitis-C virus infection. Analyzing the regulation between viral and host proteins in different organisms helps to uncover the underlying mechanism of various viral diseases. Protein-protein interaction (PPI) information provides a local as well as a global view of the interaction modules of proteins participating in similar biological activities. Such interaction information can be obtained via biological experiments or can be predicted using computational approaches [@pone.0094029-Panchenko1]. Among the experimental methods, yeast two-hybrid (Y2H) screens have been widely used by the biologists. The Y2H system can detect both transient and stable interactions. The works in [@pone.0094029-Ito1] and [@pone.0094029-Uetz1] deal with the identification of PPIs in *Saccharomyces cerevisiae* using yeast two-hybrid screens. The Y2H approach has also been utilized in the analysis of human PPIs in some earlier studies [@pone.0094029-Rual1], [@pone.0094029-Stelzl1]. Another popularly used experimental method in the context of PPI is mass spectrometry which is used to identify the components of protein complexes. Use of mass spectrometry method for detecting PPIs can be found in [@pone.0094029-Gavin1], [@pone.0094029-Ho1].

One of the main goals in research of PPI is to predict possible viral-host interactions. This interaction information can be utilized to identify and prioritize the important viral-host interactions. This is specifically aimed at assisting drug developers targeting protein interactions for the development of specially designed small molecules to inhibit potential HCV-Human PPIs. Targeting protein-protein interactions has relatively recently been established to be a promising alternative to the conventional approach to drug design [@pone.0094029-Huang1], [@pone.0094029-Arkin1].

Although there have been many studies on determining and analyzing PPIs in a single organism, not much work can be found on computational analysis of viral-host interactions. In very recent times, some computational analysis of viral-host interactions, specially in HIV-1-human PPIs [@pone.0094029-Tastan1]--[@pone.0094029-Mukhopadhyay3] have been done. Some recent studies have analyzed the viral-host interactions for some individual HCV proteins. For example, in [@pone.0094029-Lorenz1], a study on NS2 protein of HCV is conducted and its role in HCV life cycle is discussed. In [@pone.0094029-Tripathi1], the interactions of HCV proteins CORE and NS4B with human proteins have been analyzed for understanding the biological context in HCV pathogenesis. In [@pone.0094029-Popescu1], the authors have revealed that the HCV protein NS2 interacts with different structural and non-structural proteins for virus assembly. In another work [@pone.0094029-Zheng1], an integrative network analysis is performed to identify key genes and pathways in the progression of hepatitis C virus induced hepatocellular carcinoma. However, no global system-wide study based on the HCV-human interaction network is available in literature. Motivated by this, in the present work, the PPI records between HCV proteins and human (*Homo sapiens*) proteins reported in a recently published dataset [@pone.0094029-Kwofie1] are collected. This interaction information, all together, can be visualized as a bipartite graph, where two sets of nodes denote HCV proteins and human proteins, respectively, and the edges denote the interactions. In this work, the bipartite network is mined to identify the strong interacting modules, which are effectively quasi-bicliques. We further extend the study by clustering the human protein-protein interaction network to identify the possible quasi-cliques that overlap with the quasi-bicliques identified in the previous step. The human proteins participating in these quasi-cliques are considered as gateways of infection and are further investigated for their functional characteristics. Subsequently, the bipartite network representing the association of human proteins with various disease types is mined to find possible quasi-bicliques that overlap with the gateway proteins discovered in the previous stage. Thus we explore three networks, namely, HCV-human interaction network, human protein interaction network, and human proteins-disease association network globally to discover the potential pathways of infection by the HCV viruses that lead to various diseases including cancers. The analyses done in this study may provide possible targets for more effective anti-hepatitis-C therapeutic involvement.

Materials and Methods {#s2}
=====================

In the present study, three different networks are mined. First one is the HCV-human protein interaction network. This network is modeled as a bipartite graph with two sets of nodes, one set corresponding to the HCV proteins and the other set corresponding to the human proteins. The edges represent presence of interactions between the corresponding HCV and human proteins. The second network is human protein interaction network, which is modeled as a graph. Nodes represent the human proteins and the edges represent interactions among them. The third network represents the associations between human proteins and disease. Hence this disease association network is also modeled as a bipartite graph with two sets of nodes representing human proteins and diseases, respectively. The edges of this graph represent the association of the human proteins with diseases.

Before describing the proposed methods, here we first define a few terms to help subsequent discussions [@pone.0094029-Bhattacharyya1],[@pone.0094029-Bhattacharyya2].

**Definition 1** (Graph). The term graph is used throughout to denote an unweighted and undirected simple graph (without self-loops or parallel edges) , where *V* and *E* are the vertex and edge sets, respectively. Here *E* is represented as a set of vertex-pairs, i.e., .

**Definition 2** (Degree of a Vertex). The degree of a vertex *v~i~*, denoted as *d*(*v~i~*) in a graph, is said to be the number of edges incident to it. Hence .

A graph may contain subgraphs. A clique is a complete subgraph of a graph.

**Definition 3** (Clique). A subgraph is said to be a clique if for each vertex pair , there is an edge .

As can be seen, the edge set *E* of a clique can readily be obtained from the vertex set *V*, and therefore a clique may be simply denoted as *G* = *V*.

**Definition 4** (*γ*-quasi-clique). In a graph , a subgraph , , , is said to be a *γ*-quasi-clique if the subgraph induced by this set of vertices contains at least edges.

We denote the cardinality of a vertex set *V* as \|*V*\|. A graph is bipartite if its vertex set can be distinguished into a pair of partitions. It is formally defined as follows.

**Definition 5** (Bipartite graph). A graph is said to be bipartite if its vertex set *V* can be partitioned into two nonempty and disjoint sets *V* ~1~ and *V* ~2~ such that .

Therefore, a bipartite graph can also be represented as . As the graphs may have subgraphs, bipartite graphs may also contain subgraphs. A biclique is a complete bipartite subgraph.

**Definition 6** (Biclique). A bipartite subgraph is said to be a biclique if for each vertex pair and , there is an edge .

As can be seen, the edge set *E* of a biclique can be readily obtained from the two vertex sets , and therefore a biclique may be simply denoted as .

**Definition 7** (*γ*-quasi-biclique). In a bipartite graph , a bipartite subgraph , , , , is said to be a *γ*-quasi-biclique if the subgraph induced by these two sets of vertices contains at least edges.

The proposed study consists of three stages. First we mine strong *γ*-quasi-bicliques from the first bipartite graph that represents the interactions between viral and human proteins. The obtained quasi-bicliques are strong interaction modules consisting of the HCV and human proteins. Thereafter, in the second stage we cluster the human protein-protein interaction network to identify the possible strong *γ*-quasi-cliques that overlap with the quasi-bicliques identified in the previous step. The human proteins participating in these quasi-cliques are considered as gateways of infection and are further investigated for their functional characteristics. Subsequently, the bipartite network representing the association of human proteins with various disease types is mined to find possible strong *γ*-quasi-bicliques that overlap with the gateway proteins discovered in the previous stage. Hence we explore three networks, namely, HCV-human interaction network, human protein interaction network, and human proteins-disease association network globally to discover the potential pathways of infection by the HCV viruses that lead to various diseases including cancers. [Fig. 1](#pone-0094029-g001){ref-type="fig"} diagrammatically demonstrates the study conducted in this article.

![The diagrammatic representation of the proposed study.\
The orange circles represent the HCV proteins. The blue circles represent the human proteins. The pink circles represent the diseases. The green edges represent the interaction between HCV proteins and human proteins. The black edges represent the interactions among human proteins. The violet edges represent the associations between human proteins and diseases. The quasi-bicliques and bicliques are shown also. The quasi-biclique in the HCV-human bipartite network overlaps with the quasi-clique in the human protein interaction network. The quasi-clique in the human protein interaction network overlaps with the quasi-biclique in the human protein-disease association network.](pone.0094029.g001){#pone-0094029-g001}

In this article we have proposed an algorithm based on hierarchical clustering that can mine both *γ*-quasi-cliques and *γ*-quasi-bicliques from graphs and bipartite graphs, respectively. The algorithm is basically a quasi-clique mining algorithm, however, with a little modification, this can also be used to mine quasi-bicliques as well. First we describe the algorithm for mining quasi-cliques from a graph. Thereafter, how this algorithm is modified to mine quasi-bicliques is described below.

Mining *γ*-Quasi-Cliques {#s2a}
------------------------

The proposed algorithm for mining *γ*-quasi-cliques is based on hierarchical average linkage clustering method [@pone.0094029-Jain1], [@pone.0094029-Mukhopadhyay4]. Given an input graph , first the shortest path distances (number of edges) between all pairs of vertices are computed. Thereafter the dendrogram is built using agglomerative average linkage method. In this method, first a cluster is formed corresponding to each vertex of the graph. Thereafter two nearest vertices as per shortest path distance are combined to form a new cluster. This continues until there remains only one cluster containing all the vertices. The distance between any two cluster is computed as the average distance between all the vertices in the two clusters. The tree representing the hierarchical relationships among the clusters formed in this way is called the dendrogram.

After building the dendrogram, we start scanning from the top of the dendrogram to the bottom, one step at a time. Every time a cluster is divided into two, we examine the two clusters whether they are *γ*-quasi-cliques given a *γ* value. If any cluster satisfies this criterion, we do not further divide that cluster, i.e., the subtree rooted by this cluster is no more explored and this cluster is returned as one *γ*-quasi-clique. The clusters that are not *γ*-quasi-cliques are recursively divided as per the dendrogram until they provide some *γ*-quasi-clique, or reaches the threshold of quasi-clique size (minimum number of vertices to be present in the quasi-clique). Hence, the algorithm returns a set of maximal *γ*-quasi-cliques, i.e., the *γ*-quasi-cliques which are not completely included in another *γ*-quasi-clique.

Mining *γ*-Quasi-Bicliques {#s2b}
--------------------------

The algorithm for mining *γ*-quasi-bicliques, which are equivalent to biclusters [@pone.0094029-Mukhopadhyay5], is exactly same as mining *γ*-quasi-cliques, the only modification is done in the distance matrix. In this case also, we compute the shortest path between the nodes in the input bipartite graph . Note that here the distance between two vertices and can be any odd value ≥1, since *u* and *v* may not be directly connected, but there may be a path between this two that contains a number of vertices from *V* ~1~ and *V* ~2~ in alternative positions. Any two vertices are never connected directly in a bipartite graph, however they may be connected through a set of vertices from *V* ~2~ and *V* ~1~ in an alternative fashion, and thus the distance between any two vertices in *V* ~1~ is always an even value ≥2. Similar is the case for any two vertices in set *V* ~2~.

In our study, The number of HCV proteins (set *V* ~1~) is far more less than the number of human proteins (set *V* ~2~). Therefore to increase the participation of HCV proteins in the *γ*-quasi-bicliques, we have modified the distance function between two viral proteins. In the modified version, the distance between any two viral proteins that are connected by a series of alternative human and viral proteins, i.e., which belong to the same connected component in the bipartite graph, is made 1. Thus the viral proteins that belong to the same connected component come closer to each other virtually and the number of viral proteins in the *γ*-quasi-cliques increases. The similar approach is adopted while finding the quasi-bicliques between the human proteins and diseases to increase the participation of the human proteins.

Databases and Preprocessing {#s2c}
---------------------------

As stated before, we deal with three networks, namely, HCV-human PPI network, human PPI network and human protein-disease association network. In this section, the collection and preprocessing of the datasets have been described below.

HCV-Human Protein Interaction Database {#s2d}
--------------------------------------

The protein interaction information between the HCV proteins and human proteins have been collected from a recently developed HCV-human protein interaction database called HCVpro [@pone.0094029-Kwofie1] publicly available at <http://cbrc.kaust.edu.sa/hcvpro/>. This viral-host PPI database has been manually curated and it stores only those HCV-human PPIs that pass through a very strict filtering process [@pone.0094029-Kwofie1]. Hence this repository maintains a very high-quality PPI information. It can be noted that there is another well-known and widely used database of hepatitis C-human protein interactions which is available at [@pone.0094029-deChassey1]. However, we found that the HCVpro database covers ∼94% of the interactions present in that database. Therefore we decided to use the newer database HCVpro. The HCVpro database contains the interactions among 11 HCV proteins (CORE, E1, E2, F, NS2, NS3, NS4A, NS4B, NS5A, NS5B, p7) and 455 human proteins. The total number of interactions is 549. The interactions are given in [File S1](#pone.0094029.s001){ref-type="supplementary-material"}. [Fig. 2](#pone-0094029-g002){ref-type="fig"} shows the distribution of the interactions with respect to each of the HCV proteins. It is evident from the figure that the HCV protein NS3 interacts with maximum number of human proteins (218), whereas NS2 is found to interact with minimum number of human proteins (8). Among the other HCV proteins, NS5A and CORE have reasonable number of interactions with the human proteins (115 and 94, respectively). After removing the redundant interactions, the number of unique interactions reduces to 524. These 524 interactions among 11 HCV proteins and 455 human proteins are used for preparing the bipartite network between viral and host proteins and the maximal *γ*-quasi-bicliques are mined from this bipartite network as described in the previous section.

![Distribution of interactions in the Hepatitis-C-Human bipartite interaction network with respect to the 11 HCV proteins.\
The HCV protein NS3 interacts with maximum number of human proteins (218), whereas NS2 is found to interact with minimum number of human proteins (8). Among the other HCV proteins, NS5A and CORE have reasonable number of interactions with the human proteins (115 and 94, respectively).](pone.0094029.g002){#pone-0094029-g002}

Human Protein Interaction Database {#s2e}
----------------------------------

The primary objective of mining human protein interaction database is to find *γ*-quasi-cliques that overlap with the *γ*-quasi-bicliques identified in the previous stage of the study. Hence to avoid huge computational complexity in mining quasi-cliques from the complete human protein interaction database, we concentrate only on the part of the human PPI that contains the human proteins present in the identified *γ*-quasi-bicliques in the previous stage. For this, the function protein association network STRING (<http://string-db.org/>) has been utilized. For each quasi-biclique identified in the previous stage, the participating human proteins are given as input to STRING and STRING generates an interactome containing these human proteins and other additional human proteins. We consider the predictions based on co-expression, experiments and databases only. We consider only the interactions with confidence of at least 0.8 (in a confidence scale between 0 and 1). This ensures that we consider only those PPIs that have reasonable number of evidences in literature. Maximum number of interactions per protein is set to 100. From the resultant PPI, the *γ*-quasi-clique mining algorithm described in previous section is applied to obtain any quasi-clique that overlaps the previously mined quasi-biclique on which the present human PPI has been built.

Human Protein-Disease Association Database {#s2f}
------------------------------------------

The Genetic Disease Association Database [@pone.0094029-Zhang1] (<http://geneticassociationdb.nih.gov/>) archives the human genetic association studies on various types of complex diseases and disorders. The database contains summary data extracted from published articles in peer reviewed journals on candidate gene and GWAS studies. The database contains both positive (if the gene/protein is known to have association with the phenotype) and negative (if a gene/protein is known to have lack of association with the phenotype) associations, and also unknown (no specific information) associations. The network has been given in [File S3](#pone.0094029.s003){ref-type="supplementary-material"}. All the gene-disease association information have been downloaded from the database and the associations other than positive ones are filtered out. We found approximately 4200 unique diseases which are associated with approximately 3600 human genes/proteins, resulting approximately a total of 12400 unique gene-disease associations. In [Fig. 3](#pone-0094029-g003){ref-type="fig"}, we have demonstrated the distributions of associations with respect to both diseases and genes. In both cases, it can be noticed that only few diseases have association with many human proteins, but most of the diseases are associated with only a few human proteins. The density of this bipartite network in ∼0.0007 only, which indicates the sparseness of the network. The human proteins belonging to the quasi-cliques identified in the previous stage are considered and the bipartite network with these human proteins and diseases connected to them is formed. Thereafter, the *γ*-quasi-biclique mining algorithm is applied to this bipartite network to obtain the strong maximal quasi-bicliques from this network.

![Distribution of associations in the human gene-disease association network.\
The left hand side figure shows the distribution of associations with respect to all the disease. The right hand side figure shows the distribution of associations with respect to all the genes.](pone.0094029.g003){#pone-0094029-g003}

Results and Discussion {#s3}
======================

In this section, we discuss the results of the proposed study.

Mining Quasi-Bicliques in HCV-Human Protein Interaction Network {#s3a}
---------------------------------------------------------------

First we apply the proposed *γ*-quasi-biclique mining algorithm on the HCV-human protein interaction network collected from HCVpro. The value of *γ* has been set to 0.5. This is done as follows. We varied *γ* value from 0.1 to 0.9 with step size 0.1 and varied the minimum number of HCV proteins present in a quasi-biclique *n* from 2 to 5 with step size 1. For each combination of *γ* and *n* the algorithm is executed. In each case, the statistical significance of the set of resultant quasi-bicliques (if found) is investigated. To test the statistical significance of a quasi-biclique of size *x*×*y*, the bipartite graph is perturbed randomly 10,000 times (without changing the degrees of HCV proteins) and a quasi-biclique of size *x*×*y* is picked up randomly from the perturbed graph. Then we conduct the Wilcoxon ranksum test to find whether the density of the actual quasi-biclique is significantly better than the mean density of the random quasi-bicliques of same size. This returns a p-value and lower the p-value more significant is the quasi-biclique under consideration. For a combination of *γ* and *n* value, the average p-value over all the quasi-bicliques obtained is computed and we found that for *γ* = 0.5 and *n* = 3 the average p-value is minimum. Hence we set the *γ* value to 0.5 and quasi-bicliques having at least three HCV proteins (*n* = 3) are considered only. This results in two quasi-bicliques and , respectively. Different statistics about the two quasi-bicliques found are reported in [Table 1](#pone-0094029-t001){ref-type="table"}. The densities (i.e., ratio of the maximum number of interactions present in the quasi-biclique to the maximum possible number of interactions) of the two quasi-bicliques obtained are 0.6786 and 0.5400, respectively. The first quasi-biclique consists of the HCV proteins CORE, NS3 and NS5A and 28 human proteins. Note that these three HCV proteins are the top three highest degree HCV proteins in the network. The other quasi-biclique consists of five HCV proteins E1, E2, NS2, NS4A and NS5B and 10 human proteins.

10.1371/journal.pone.0094029.t001

###### Quasi-bicliques found from HCV-human protein interaction database.

![](pone.0094029.t001){#pone-0094029-t001-1}

  Quasi-biclique         HCV proteins                                                                                                    Human proteins                                                                                              Density
  ---------------- ------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ---------
  *QB*1                    Count: 3                                                                                                        Count: 28                                                                                                
                        CORE, NS3, NS5A       EFEMP1, EIF2AK2, FBLN2, FBLN5, FTH1, HIVEP2, HNRNPK, JAK1, KPNA1, LTBP4, MAGED1, NAP1L1, NAP1L2, PSMB9, PSME3, RNF31, SMAD3, STAT1, STAT3, TBP, TLR2, TP53, TP53BP2, TRADD, TRAF2, TXNDC11, VIM, VWF   0.6786
  *QB*2                    Count: 5                                                                                                        Count: 10                                                                                                
                    E1, E2, NS2, NS4A, NS5B                                                                    CALR, CANX, CD209, CLEC4M, HOXD8, HSPA5, LTF, NR4A1, SETD2, UBQLN1                                                                    0.5400

The HCV proteins and human proteins involved in the quasi-bicliques are reported along with the densities of the quasi-bicliques.

Mining Quasi-Cliques in Human Protein Interaction Network {#s3b}
---------------------------------------------------------

In the next stage, as discussed before, the human proteins participating in the quasi-bicliques are given as the input to the STRING database. The human proteins involved in the first quasi-biclique ([Table 1](#pone-0094029-t001){ref-type="table"}) are first given to the STRING database with the parameter setting described in Section. This induces a human interactome consisting of 120 human proteins ([Fig. 4](#pone-0094029-g004){ref-type="fig"} shows the interactome). Although this network is very sparse (density ∼0.07), a few denser regions are clearly visible from the figure. After applying the quasi-clique mining algorithm described before. The *γ* value is fixed to 0.6 and the minimum number of nodes allowed is set to 4. We obtained 9 dense quasi-cliques from the interactome. Out of these 9 quasi-cliques, 5 have overlaps with the first quasi-biclique discovered in the previous stage. Different statistics of these 5 quasi-cliques are shown in [Table 2](#pone-0094029-t002){ref-type="table"}.

![Human protein interactome induced by first quasi-biclique QB1.\
The interactome consists of 120 human proteins and 509 interactions among them. The density of the interactome is nearly 0.07.](pone.0094029.g004){#pone-0094029-g004}

10.1371/journal.pone.0094029.t002

###### Quasi-cliques found from human protein interactome that overlap with the human proteins involved in the first quasi-biclique of [Table 1](#pone-0094029-t001){ref-type="table"}.

![](pone.0094029.t002){#pone-0094029-t002-2}

  Quasi-clique                                                                         Human proteins                                                                         Density   Overlapping proteins with first quasi-clique
  -------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------- --------- ----------------------------------------------
  *QC*1                                                                                   Count: 8                                                                                     
                                                                   POMP, PSMA2, PSMB10, PSMB7, PSMB8, PSMB9, PSME3, RFWD2                                                     0.6786                    PSMB9, PSME3
  *QC*2                                                                                   Count: 14                                                                                    
                                             BIRC2, BIRC3, CASP8, FADD, GATA5, MAP3K5, RIPK1, TNFRSF1A, TNFRSF1B, TRADD, TRAF1, TRAF2, UBC, VIM                               0.6484                 TRADD, TRAF2, VIM
  *QC*3                                                                                   Count: 23                                                                                    
                  CIP, EDF1, GTF2A1, GTF2A2, GTF2B, GTF2E1, GTF2F1, HNRNPK, MYST1, SETD7, SF3A2, TAF1, TAF10, TAF11, TAF12, TAF13, TAF2, TAF2E, TAF3, TAF4, TAF5, TAF7, TBP   0.6324                    HNRNPK, TBP
  *QC*4                                                                                   Count: 8                                                                                     
                                                                     HDAC1, HIPK2, MDM2, MDM4, SUMO1, TP53, UBE2I, USp7                                                       0.6429                        TP53
  *QC*5                                                                                   Count: 8                                                                                     
                                                                     EGFR, IL6ST, JAK1, PIAS3, SRC, STAT1, STAT2, STAT3                                                       0.7143                 JAK1, STAT1, STAT3

The human proteins involved in the quasi-cliques are reported along with the densities of the quasi-cliques and the overlapping human proteins with the first quasi-biclique.

After application of the quasi-clique finding algorithm on the interactome induced by the second quasi-biclique of [Table 1](#pone-0094029-t001){ref-type="table"}, it provides 4 quasi-cliques that overlap this quasi-biclique. The interactome induced by the second quasi-biclique consists of 79 human proteins (This interactome has been shown in [Fig. 5](#pone-0094029-g005){ref-type="fig"}). This network has density of ∼0.22. However, here also, a few denser regions can be noticed from the figure. The 4 quasi-cliques as found by the algorithm have been reported in [Table 3](#pone-0094029-t003){ref-type="table"}. It is evident from the table that these quasi-cliques overlap with the second quasi-biclique on only one human protein each. Both the human interactomes induced by quasi-bicliques and are reported in [File S2](#pone.0094029.s002){ref-type="supplementary-material"}. All the quasi-bicliques and quasi-cliques are reported in [File S4](#pone.0094029.s004){ref-type="supplementary-material"}.

![Human protein interactome induced by second quasi-biclique QB2.\
The interactome consists of 79 human proteins and 693 interactions among them. The density of the interactome is nearly 0.22.](pone.0094029.g005){#pone-0094029-g005}

10.1371/journal.pone.0094029.t003

###### Quasi-cliques found from human protein interactome that overlap with the human proteins involved in the second quasi-biclique of [Table 1](#pone-0094029-t001){ref-type="table"}.

![](pone.0094029.t003){#pone-0094029-t003-3}

  Quasi-clique                                                                                                                                                  Human proteins                                                                                                                                                 Density   Overlapping proteins with second quasi-biclique
  -------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ --------- -------------------------------------------------
  *QC*6                                                                                                                                                            Count: 4                                                                                                                                                             
                                                                                                                                                          PLOD1, PLOD2, PLOD3, SETD2                                                                                                                                           0.8333                         SETD2
  *QC*7                                                                                                                                                            Count: 5                                                                                                                                                             
                                                                                                                                                       NBL1, PSMD4, UBA52, UBC, UBQLN1                                                                                                                                         0.7000                        UBQLN1
  *QC*8                                                                                                                                                           Count: 45                                                                                                                                                             
                  BCL2, CD3D, CREBBP, EP300, ESR1, ESR2, ESRRA, ESRRB, ESRRG, FOSB, GNG2, HNF4A, HNF4G, MAPK7, MEF2D, NFATC2, NR0B2, NR1D1, NR1D2, NR1H2, NR2C1, NR2C2, NR2C2AP, NR2E1, NR2F1, NR2F6, NR4A1, NR4A2, NR5A1, NRBP1, POMC, PPARA, PPARD, PPARG, RARA, RARB, RARG, RORA, RORB, RORC, RXRA, RXRG, THRA, THRB, VDR   0.6364                         NR4A1
  *QC*9                                                                                                                                                            Count: 5                                                                                                                                                             
                                                                                                                                                         APOB, C1QA, C1QB, C1QC, CALR                                                                                                                                          0.7000                         CALR

The human proteins involved in the quasi-cliques are reported along with the densities of the quasi-cliques and the overlapping human proteins with the second quasi-biclique.

GO and Pathway Analyses of Quasi-Cliques {#s3c}
----------------------------------------

Subsequently we further analyze the quasi-cliques found ([Tables 2](#pone-0094029-t002){ref-type="table"} and [3](#pone-0094029-t003){ref-type="table"}) using Gene Ontology (GO) and pathway based studies. Let us denote the 9 quasi-cliques of [Table 2](#pone-0094029-t002){ref-type="table"} and [3](#pone-0094029-t003){ref-type="table"} by respectively. For the GO and pathway analyses, the web-based tool DAVID (<http://david.abcc.ncifcrf.gov/>) has been used. [Table 4](#pone-0094029-t004){ref-type="table"} shows the top few significant GO and KEGG pathway terms for the 9 quasi-cliques along with the significance p-values. It is evident from the table that for all the quasi-cliques have significant GO and KEGG pathways associated with them, with one exception for for which no significant KEGG pathway has been found. mainly consists of the proteins that function in negative regulation of ubiquitin and participate in proteasome complex whose main function is to degrade unneeded or damaged proteins by proteolysis, a chemical reaction that breaks peptide bonds. The relationship between ubiquitin, proteasome and hepatitis-c have already been reported in literature [@pone.0094029-Osna1], [@pone.0094029-Suzuki1] which involves HCV protein CORE. It may be noticed that the HCV CORE protein belongs to the first quasi-biclique ( in [Table 1](#pone-0094029-t001){ref-type="table"}, that has overlaps with the quasi-clique . The overlap between and consists of two human proteins PSMB9 and PSME3 and thus they may be considered as possible infection gateway by the HCV proteins CORE (interacts with PSME3), NS3 (interacts with PSMB9) and NS5A (interacts with PSMB9) which belong to quasi-biclique , for attacking the proteasome complex.

10.1371/journal.pone.0094029.t004

###### The significant important GO terms and KEGG pathways found in the quasi-cliques.

![](pone.0094029.t004){#pone-0094029-t004-4}

  Quasi-clique                                                                                                                      Significant GO terms                                                                             KEGG Pathway
  -------------- ------------------------------------------------------------------------------------------------ --------------------------------------------------------- -------------------------------------------- -------------------------------------
  *QC*1                 negative regulation of ubiquitin-protein ligase activity during mitotic cell cycle                  threonine-type endopeptidase activity                        proteasome complex                           Proteasome
                                                     (p-value: 4.6e-11, 75%)                                                      (p-value: 6.1e-11, 62.5%)                          (p-value: 6.4e-14, 87.5%)                 (p-value: 3.1e-12, 87.5%)
  *QC*2                                                     apoptosis                                                               death domain binding                                   membrane raft                               Apoptosis
                                                    (p-value: 8.9e-14, 85.7%)                                                     (p-value: 5.0e-3, 14.3%)                            (p-value: 3.9e-8, 42.9%)                 (p-value: 1.1e-10, 57.1%)
                                                      programmed cell death                                                                                                       death-inducing signaling complex                pathways in cancer
                                                    (p-value: 1.1e-13, 85.7%)                                                                                                         (p-value: 5.5e-6, 21.4%)                 (p-value: 3.6e-4, 42.9%)
  *QC*3                              transcription initiation from RNA polymerase II promoter                      general RNA polymerase II transcription factor activity   DNA-directed RNA polymerase II, holoenzyme       Basal transcription factors
                                                    (p-value: 6.0e-29, 71.4%)                                                     (p-value: 4.9e-20, 52.4%)                          (p-value: 4.1e-30, 76.2%)                 (p-value: 1.8e-29, 71.4%)
  *QC*4                                        negative regulation of transcription                                                    enzyme binding                                         PML body                           p53 signaling pathway
                                                     (p-value: 1.0e-8, 87.5%)                                                    (p-value: 1.2e-3, 50.0%, )                           (p-value: 1.6e-7, 50.0%)                 (p-value: 1.0e-3, 37.5%)
                                                                                                                                                                                                                               Chronic myeloid leukemia
                                                                                                                                                                                                                               (p-value: 1.3e-3, 37.5%)
  *QC*5                                               protein kinase cascade                                                  protein tyrosine kinase activity                                dendrite                        Jak-STAT signaling pathway
                                                     (p-value: 2.8e-9, 87.5%)                                                     (p-value: 3.3e-3, 37.5%)                            (p-value: 7.4e-2, 25.0%)                 (p-value: 4.9e-7, 75.0%)
                                                                                                                                                                                                                                   Pancreatic cancer
                                                                                                                                                                                                                               (p-value: 9.1e-5, 50.0%)
  *QC*6                                                oxidation reduction                                                procollagen-lysine 5-dioxygenase activity                    endoplasmic reticulum                      Lysine degradation
                                                    (p-value: 1.0e-4, 100.0%)                                                     (p-value: 1.1e-7, 75.0%)                            (p-value: 5.6e-3, 75.0%)                 (p-value: 6.0e-7, 100.0%)
  *QC*7           anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process             structural constituent of ribosome                  cytosolic small ribosomal subunit       
                                                     (p-value: 2.3e-5, 60.0%)                                                     (p-value: 2.6e-2, 40.0%)                            (p-value: 1.2e-2, 40.0%)                            --
                                                                                                                                                                                         proteasome complex              
                                                                                                                                                                                      (p-value: 1.9e-2, 40.0%)           
  *QC*8                                     regulation of transcription, DNA-dependent                                        steroid hormone receptor activity                            nuclear lumen                          Pathways in cancer
                                                    (p-value: 4.3e-27, 84.4%)                                                     (p-value: 6.1e-75, 73.3%)                           (p-value: 1.4e-3, 20.0%)                 (p-value: 1.7e-5, 20.0%)
                                                                                                                                transcription factor activity                       transcription factor complex                PPAR signaling pathway
                                                                                                                                  (p-value: 7.7e-37, 84.4%)                           (p-value: 4.7e-3, 8.9%)                  (p-value: 1.3e-4, 11.1%)
  *QC*9                                                 protein maturation                                                          carbohydrate binding                                extracellular space                         Prion diseases
                                                     (p-value: 2.8e-6, 80.0%)                                                     (p-value: 5.4e-2, 40.0%)                            (p-value: 5.9e-4, 80.0%)                 (p-value: 1.4e-4, 60.0%)
                                  humoral immune response mediated by circulating immunoglobulin                                                                                                                          Complement and coagulation cascades
                                                     (p-value: 3.0e-5, 60.0%)                                                                                                                                                  (p-value: 5.4e-4, 60.0%)
  Quasi-clique                                                                                                                      Significant GO terms                                                                             KEGG Pathway
                                                        Biological Process                                                           Molecular Function                                  Cellular Component              
  *QC*1                 negative regulation of ubiquitin-protein ligase activity during mitotic cell cycle                  threonine-type endopeptidase activity                        proteasome complex                           Proteasome
                                                     (p-value: 4.6e-11, 75%)                                                      (p-value: 6.1e-11, 62.5%)                          (p-value: 6.4e-14, 87.5%)                 (p-value: 3.1e-12, 87.5%)
  *QC*2                                                     apoptosis                                                               death domain binding                                   membrane raft                               Apoptosis

The significant terms are mentioned along with their significance p-values and percentage of proteins associated with each term. DAVID online tool has been used to perform the significance tests.

The quasi-clique contains 14 human proteins mostly involved in apoptosis and programmed cell death. Also it is interesting that a significant GO-CC term for these proteins is death-inducing signaling complex. Further, these proteins also participate in the KEGG pathway apoptosis as well as pathways in cancer. These evidences suggest strongly that the human proteins involved in this quasi-clique have direct or indirect relationship to cancer diseases. The quasi-biclique (involving the viral proteins CORE, NS5A and NS3) overlaps with on three human proteins TRADD (interacts with CORE and NS5A), TRAF2 (interacts with CORE and NS5A) and VIM (interacts with CORE and NS3). This suggests that attack by HCV proteins CORE, NS5A and NS3 may lead to cancer through apoptosis and the main gateway host proteins responsible for that are TRADD, TRAF2 and VIM.

The 23 host proteins in quasi-clique are mainly transcription factors ([Table 4](#pone-0094029-t004){ref-type="table"}). Although the quasi-biclique only overlaps with on two host proteins HNRNPK and TBP, it suggests that the viral proteins in may indirectly interact with many transcription factor proteins and thus may cause their malfunctioning. This may lead to breakdown of the overall setup of normal regulatory roles of these transcription factors causing serious infectious behavior.

Most of the host proteins in the quasi-clique negatively regulate transcription and participate in enzyme binding. It can be noticed that many of these proteins are part of PML bodies, which is a class of nuclear body and they react against SP100 auto-antibodies (PML, promyelocytic leukemia). This is in fact also evident from the pathway analysis which finds two significant KEGG pathways, namely p53 signaling pathway and chronic myeloid leukemia. For the quasi-biclique the viral gateway to these host proteins is TP53, a membrane protein that is common for and . Noticeably, all the viral proteins of , i.e., CORE, NS5A and NS3 interact with TP53 to get entrance. This infection may ultimately lead to chronic myeloid leukemia [@pone.0094029-Klco1].

The quasi-clique contains host proteins with mainly kinase activities. Two significant KEGG pathways namely JAK-STAT signaling pathway and pancreatic cancer, have been identified in this quasi-clique. This suggests that the HCV proteins in interact with the host proteins in through the common host proteins JAK1, STAT1 and STAT3 leading to pancreatic cancer. Moreover, JAK-STAT system transmits information from chemical signals outside the cell, through the cell membrane. Therefore the proteins involved in are possibly involved in transferring and propagating the infection to the other cells. A study in [@pone.0094029-Zhang2] has already established the involvement of HCV in JAK-STAT signaling pathway.

The quasi-cliques through ([Table 3](#pone-0094029-t003){ref-type="table"}) overlap with the quasi-biclique , which consists of 5 viral proteins E1, E2, NS2, NS4A, and NS5B and 10 host proteins. overlaps with with the host protein SETD2. The most significant GO terms associated with the human proteins in in BP, MF and CC categories are oxidation reduction, procollagen-lysine 5-dioxygenase activity and endoplasmic reticulum, respectively. The most significant KEGG pathway associated with these proteins is Lysine degradation, where all the 4 proteins in are involved. The association of HCV NS2 protein and lysine degradation is also reported in [@pone.0094029-Welbourn1].

overlaps with the host protein UBQLN1. also has proteasomal acitivities , and as discussed before the host proteins in this functional module are involved in hepatitis C infection. However, we could not find any significant pathway for .

is the largest quasi-clique that we have found in the present study. This functional module consists of 45 host proteins which are mostly transcription factors. The infection gateway to this module is NR4A1, which is the only common host protein for and . Interestingly, all the five viral proteins in interact with NR4A1, and the CORE protein, which is a part of also interacts with NR4A1. This observation suggests that NR4A1 serves as a very important gateway to this transcription factor complex. Any disturbance to this module for viral infection may lead to malfunctioning of normal gene regulatory network, and this in turn can result in various types of cancer (as the pathway study reveals). Our pathway study also reveals another significant pathway, namely PRAR signaling pathway, which is also shown to be associated with HCV infection in recent studies [@pone.0094029-Negro1].

The quasi-clique that consists of 5 host proteins which have been found to be associated with protein maturation and humoral immune response mediated by circulating immunoglobulin. Thus these proteins are highly responsible for maintaining the immunity system inside human body. and has one common host protein CALR, and hence this protein serves as a gateway of attack to the immunity system by HCV. The viral proteins E1 and E2 (envelop proteins), which are major players in all events required for virus entry into target cells interact with CALR and start attacking the immunity system. This may ultimately lead to many prion diseases (as revealed through pathway analysis).

The GO and pathway analyses of the identified quasi-cliques in human protein interaction network reveals that the host proteins involved in these functional modules have high degree of functional similarities. Moreover, as discussed, HCV attacks that go through these quasi-cliques may lead malfunctioning of regulatory and immunity system in targeted cells and may lead to different types of disease including various types of cancers.

Mining Quasi-Bicliques in Human Protein-Disease Association Network {#s3d}
-------------------------------------------------------------------

To study the disease association with the host proteins in the identified quasi-cliques for finding possible pathway of pathogenesis leading to various diseases, we apply our quasi-biclique finding algorithm on the human gene-disease association network. Note that while finding the quasi-bicliques, we executed the quasi-biclique finding method on 9 different bipartite graphs, corresponding to the 9 quasi-cliques. Each of these graphs contain the human proteins from the corresponding quasi-clique, and all the diseases. The *γ* value is set to 0.7, so that each identified quasi-biclique has density of at least 0.7. Out of the nine quasi-cliques, we found four quasi-cliques , , and which have overlap with the obtained quasi-bicliques on protein-disease association networks. These quasi-bicliques, termed as , , , are reported in [Table 5](#pone-0094029-t005){ref-type="table"}. In each quasi-biclique in human protein-disease association network, two human proteins have been found to overlap with the corresponding quasi-cliques. These proteins, thus can be considered as gateways to the diseases. has overlap with with two proteins PSMB8 and PSMB9 which are associated with five different diseases. overlaps with with two host proteins TNFRSF1A and TNFRSF1B and these proteins are highly associated with 12 diseases. The quasi-clique and the quasi-biclique has two common proteins and which are connected two 9 diseases including various types of cancer. Two proteins TGFR and MDM2 are common to and and these proteins have association with 5 diseases which are mainly different cancer types. Interestingly MDM2 belongs to both and .

10.1371/journal.pone.0094029.t005

###### Quasi-bicliques found for human protein-disease association network corresponding to four quasi-cliques.

![](pone.0094029.t005){#pone-0094029-t005-5}

  Quasi-biclique    Corresponding *QC*     Human proteins                                                                                                                 Diseases                                                                                                               Density
  ---------------- -------------------- -------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------
  *~QBD~* ~1~             *QC*1               Count: 2                                                                                                                    Count: 5                                                                                                              
                                            PSMB8, PSMB9                                                                 Graves disease, diabetes (type 1), interferon response, psoriasis, malaria; hypoglycemia; hyperparasitemia                                                              0.7000
  *~QBD~* ~2~             *QC*2               Count: 2                                                                                                                   Count: 12                                                                                                              
                                         TNFRSF1A, TNFRSF1B   Crohn\'s disease, ulcerative colitis, cystic fibrosis, Lupus, Rheumatoid Arthritis, diabetes (type 2), amyloidosis, breast cancer, Tumor necrosis factor receptor-associated periodic syndrome, bone density, bone mass, obesity   0.7083
  *~QBD~* ~3~             *QC*4               Count: 2                                                                                                                    Count: 9                                                                                                              
                                             TP53, MDM2                              DNA Damage \| Lung Neoplasms, B-Cell Chronic Lymphocytic Leukemia, bladder cancer, breast cancer, colorectal cancer, endometrial cancer, liver cancer, lung cancer, stomach cancer                           1.000
  *~QBD~* ~4~             *QC*8               Count: 2                                                                                                                    Count: 5                                                                                                              
                                             EGFR, MDM2                                                  colorectal cancer, lung cancer, Acute Coronary Syndrome, Breast Neoplasms Carcinoma \| Non-Small-Cell Lung \| Exanthema \| Lung Neoplasms                                               0.7000

The human proteins and diseases associated with each quasi-biclique are reported along with the densities of the quasi-bicliques.

Analyses of Gateway Proteins {#s3e}
----------------------------

Previous results and discussions have pointed out two types of gateway proteins, one set acts as the gateway to the host cellular mechanism for the viral proteins, and the second set consists of the host proteins that have high degree of association to different kinds of diseases. The first set *VH* (Viral-Host) contains 15 host proteins: PSME3, TP53, TBP, TRADD, STAT3, HNRNPK, NR4A1, SETD2, PSMB9, TRAF2, STAT1, CALR, JAK1, VIM and UBQLN1 ([Tables 2](#pone-0094029-t002){ref-type="table"} and [3](#pone-0094029-t003){ref-type="table"}). The second set *HD* (Human-Disease) contains 7 host proteins PSMB8, PSMB9, TNFRSF1A, TNFRSF1B, TP53, MDM2 and EGFR. The results reveal that HCV infection pathogenesis should propagate through the proteins in *VH* and *HD* sets, and thus these proteins play extremely important role during viral infection. Specially, the proteins in the set *VH* are responsible for the initiation of the infection process. First we compare the average degrees of gateway and non-gateway proteins and found that average degree of gateway proteins is 21.6364, whereas the average degree of non-gateway proteins is 4.2295. The difference is statistically significant as per Wilcoxon\'s rank sum test (p-value: 1.3006e-09). This suggests that the viral proteins tend to attack high-degree host proteins for initiating infection. Moreover, to test whether these proteins have some unique features, we investigate for their GO (BP) and pathway enrichment ([Table 6](#pone-0094029-t006){ref-type="table"}). It is evident from the table that the significant GO-BP terms mostly involved in apoptosis and programmed cell death which indicates that the targeted host proteins are highly associated with the process of cell death. Moreover significant pathways suggest that HCV infection ultimately lead to various cancer types including pancreatic cancer which is already established in a recent study [@pone.0094029-ElSerag1].

10.1371/journal.pone.0094029.t006

###### Significant GO-BP and KEGG pathway terms for viral-human gateway proteins.
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  Significant GO-BP terms
  --------------------------------------------------------------------------
  cytokine-mediated signaling pathway (p-value: 3.7e-5)
  regulation of apoptosis (p-value: 5.2e-5)
  regulation of programmed cell death (p-value: 5.5e-5)
  regulation of cell death (p-value: 5.6e-5)
  positive regulation of macromolecule metabolic process (p-value: 7.4e-5)
  **Significant KEGG pathways**
  Pancreatic cancer (p-value: 5.5e-4)
  Pathways in cancer (p-value: 5.6e-3)

The significant terms are mentioned along with their significance p-values. DAVID online tool has been used to perform the significance tests.

Conclusions {#s4}
===========

In this article a system-wide study has been made for identifying possible infection pathway of hepatitic C virus. For this purpose, quasi-bicliques in HCV-human protein interaction network are mapped onto quasi-cliques in human protein interaction network. Subsequently, the quasi-cliques are mapped onto human protein-disease association networks. Hierarchical clustering based quasi-clique and quasi-biclique mining algorithms have been proposed in this context. The quasi-cliques that overlap with the quasi-bicliques in HCV-human protein interaction network have been found to contain host proteins highly associated in various disease pathways including different cancer types. Many of the diseases have evidence in literature for their connection with HCV infection. Further, the gateway proteins, i.e., the proteins which are mainly targeted by HCV proteins to disturb the host cellular mechanisms, are identified. These gateway proteins have been found to have high degrees in human interactome compared to the other virus-targeted proteins. Moreover, the gateway proteins are tested for GO-BP enrichment and pathway enrichment, and these analyses reveal that these proteins are highly involved in apoptosis and programmed cell death leading to various cancer types.
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